SPARCL1, a Novel Prognostic Predictive Factor for GI Malignancies: a Meta-Analysis | Zendy

Hanguang Hu | Zendy; Wen Cai | Zendy; Shu Zheng | Zendy; Weiting Ge | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

SPARCL1, a Novel Prognostic Predictive Factor for GI Malignancies: a Meta-Analysis

Author(s) -

Hanguang Hu,

Wen Cai,

Shu Zheng,

Weiting Ge

Publication year - 2017

Publication title -

cellular physiology and biochemistry

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.486

H-Index - 87

eISSN - 1421-9778

pISSN - 1015-8987

DOI - 10.1159/000485584

Subject(s) - medicine , meta analysis , publication bias , oncology , subgroup analysis , hazard ratio , cancer , colorectal cancer , lymph node metastasis , odds ratio , lymph node , metastasis , confidence interval

Secreted protein acidic and rich in cysteines-like 1 (SPARCL1) is abnormally expressed in gastrointestinal (GI) malignancies. However, the correlation between SPARCL1 expression and the prognosis of patients remains unknown. Therefore, we performed a meta-analysis to investigate the potential value of SPARCL1 as a prognostic predictive marker for GI malignancies.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research